100+
CFTR 100+ (RUO) options
Micro Solutions / Life Science
MassARRAY ready-made and customized panels for pharmacogenetics, oncology and hereditary diseases
MassARRAY ready-made and customized panels for pharmacogenetics, oncology and hereditary diseases
from a proven set of options to the development of an individual panel for the task
Agena’s targeted panels turn MassARRAY into a ready-made solution for pharmacogenetics, oncology, hereditary diseases, methylation and sample control – from a proven list of options to scalable analysis of large cohorts.
The line includes ready-made research panels and the development of customized Assays by Agena kits. Among the current areas are VeriDose for pharmacogenetics, iPLEX HS and UltraSEEK for mutational profiling and liquid biopsy, HFE and CFTR for hereditary variants, as well as methylation and sample identification panels. Each card for each set of directories offers one point of choice for a clinical or research task.
Composition, multiplexity, required chemistry, sample type, number of reactions and RUO/IVD status are determined by the specific panel and region. Examples of the current portfolio are: VeriDose Core and DPYD Plus, HFE, iPLEX HS Lung, UltraSEEK Lung and research CFTR 100+ with coverage of more than 100 options. options, catalog number, compatibility with the MassARRAY configuration and regulatory status on the official manufacturer's page.
CFTR 100+ (RUO) options
status depends on the panel
designing individual panels
ready-made
panel report
determination of the mass of the reaction
| Pharmacogenetics | VeriDose Core, VeriDose DPYD Plus |
|---|---|
| Oncology/liquid biopsy | iPLEX HS Lung, UltraSEEK Lung |
| Hereditary diseases | HFE, CFTR 100+ (research, over 100 variants) |
| Individual development | Assays by Agena – SNP, insertions/deletions, translocations, CNV, methylation |
| Defined by a specific panel | composition, multiplexity, required chemistry, sample type, number of reactions, RUO/IVD status |
|---|